What is the current annual EBITDA of RPRX?

As of today, RPRX annual EBITDA is $1.56B

What is 1-year change in RPRX annual EBITDA?

RPRX annual EBITDA is up +20.96% year-over-year

What is 3-year change in RPRX annual EBITDA?

RPRX annual EBITDA is up +68.36% over the past 3 years

How far is RPRX annual EBITDA from its all-time high?

RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on December 31, 2019

How does RPRX annual EBITDA rank versus sector peers?

RPRX annual EBITDA is higher than 94.53% of companies in Healthcare sector

When is RPRX next annual earnings release?

As of today, the next annual earnings release for RPRX has not been scheduled

What is the current quarterly EBITDA of RPRX?

As of today, RPRX quarterly EBITDA is $134.41M

What is RPRX quarterly EBITDA most recent change?

RPRX quarterly EBITDA was down -78.79% on June 30, 2026

What is 1-year change in RPRX quarterly EBITDA?

RPRX quarterly EBITDA is down -35.93% year-over-year

How far is RPRX quarterly EBITDA from its all-time high?

RPRX quarterly EBITDA is currently -89.95% below its historical high of $1.34B set on December 31, 2019

How does RPRX quarterly EBITDA rank versus sector peers?

RPRX quarterly EBITDA is higher than 89.25% of companies in Healthcare sector

When is RPRX next earnings release?

The next earnings release for RPRX is on November 4, 2026

What is the current TTM EBITDA of RPRX?

As of today, RPRX TTM EBITDA is $1.59B

What is RPRX TTM EBITDA most recent change?

RPRX TTM EBITDA was down -4.54% on June 30, 2026

What is 1-year change in RPRX TTM EBITDA?

RPRX TTM EBITDA is down -13.82% year-over-year

How far is RPRX TTM EBITDA from its all-time high?

RPRX TTM EBITDA is currently -40.35% below its historical high of $2.66B set on June 30, 2020

How does RPRX TTM EBITDA rank versus sector peers?

RPRX TTM EBITDA is higher than 94.29% of companies in Healthcare sector

When is RPRX next earnings release?

The next earnings release for RPRX is on November 4, 2026

RPRX EBITDA History & Chart Since 2015

Annual EBITDA

$1.56B$270.93M+20.96%

December 31, 2025

Summary

Current Value: As of today, RPRX annual EBITDA is $1.56B, up +20.96% on December 31, 2025
Historical Performance: RPRX annual EBITDA is up +68.36% over the past 3 years, down -3.40% over the past 5 years
All-Time High Comparison: RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on December 31, 2019
3-Year Low Comparison: RPRX annual EBITDA is +68.36% above its 3-year low of $928.56M reached on an earlier date
Sector Comparison: RPRX annual EBITDA is higher than 94.53% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

RPRX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$1.56B	+21.0%	+68.4%	-3.4%	+81.3%
Quarterly EBITDA	Jun 30, 26	$134.41M	-35.9%	-46.0%	-82.1%	-69.3%
TTM EBITDA	Jun 30, 26	$1.59B	-13.8%	+50.6%	-13.0%	+262.4%
Price	Aug 14, 26	$58.60	+60.5%	+94.6%	+51.3%	–
PE Ratio	Aug 14, 26	31.20	+85.5%	-41.5%	+99.7%	–
Annual Revenue	Dec 31, 25	$2.38B	+5.1%	+6.3%	+12.1%	+43.9%
Annual EPS	Dec 31, 25	$1.78	-6.8%	+1721.5%	-31.4%	+86.0%
	Dec 31, 25	$1.56B	+20.7%	+69.0%	-2.3%	+96.3%
Annual Net Income	Dec 31, 25	$1.32B	-0.5%	+475.6%	-22.2%	+74.5%

EBITDA Highs

RPRX Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.56B	Dec 31, 25	at high
5Y	$1.62B	N/A	-3.4%
All	$2.65B	Dec 31, 19	-40.9%

EBITDA Lows

RPRX Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$928.56M	N/A	+68.4%
5Y	$928.56M	Dec 31, 22	+68.4%
All	$791.08M	Dec 1, 16	+97.6%

EBITDA History

Year	Value	Change
2025	$1.56B	+21.0%
2024	$1.29B	-13.4%
2023	$1.49B	+60.7%
2022	$928.56M	-36.1%
2021	$1.45B	-10.2%
2020	$1.62B	-38.9%

Year	Value	Change
2019	$2.65B	+89.4%
2018	$1.40B	+43.7%
2017	$972.96M	+23.0%
2016	$791.08M	-8.3%
2015	$862.44M	-

FAQ

What is the current annual EBITDA of RPRX?: As of today, RPRX annual EBITDA is $1.56B
What is 1-year change in RPRX annual EBITDA?: RPRX annual EBITDA is up +20.96% year-over-year
What is 3-year change in RPRX annual EBITDA?: RPRX annual EBITDA is up +68.36% over the past 3 years
How far is RPRX annual EBITDA from its all-time high?: RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on December 31, 2019
How does RPRX annual EBITDA rank versus sector peers?: RPRX annual EBITDA is higher than 94.53% of companies in Healthcare sector
When is RPRX next annual earnings release?: As of today, the next annual earnings release for RPRX has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$134.41M$499.24M-78.79%

June 30, 2026

Summary

Current Value: As of today, RPRX quarterly EBITDA is $134.41M, down -78.79% on June 30, 2026
Historical Performance: RPRX quarterly EBITDA is down -35.93% year-over-year, down -45.98% over the past 3 years
All-Time High Comparison: RPRX quarterly EBITDA is currently -89.95% below its historical high of $1.34B set on December 31, 2019
3-Year Low Comparison: RPRX quarterly EBITDA is +282.20% above its 3-year low of -$73.77M reached on March 31, 2024
Sector Comparison: RPRX quarterly EBITDA is higher than 89.25% of companies in Healthcare sector

Performance

RPRX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	$134.41M	-78.8%	-35.9%	-46.0%	-82.1%
Annual EBITDA	Dec 31, 25	$1.56B	–	+21.0%	+68.4%	-3.4%
TTM EBITDA	Jun 30, 26	$1.59B	-4.5%	-13.8%	+50.6%	-13.0%
Price	Aug 14, 26	$58.60	+9.7%	+60.5%	+94.6%	+51.3%
PE Ratio	Aug 14, 26	31.20	+11.8%	+85.5%	-41.5%	+99.7%
Quarterly Revenue	Jun 30, 26	$674.14M	+6.9%	+16.5%	+25.3%	+21.5%
Quarterly EPS	Jun 30, 26	$0.04	-94.1%	-46.3%	-92.1%	-96.3%
	Jun 30, 26	$133.12M	-79.0%	-36.5%	-46.5%	-82.1%
Quarterly Net Income	Jun 30, 26	$81.49M	-82.6%	-12.0%	-76.8%	-89.9%

Quarterly EBITDA Highs

RPRX Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$633.65M	Mar 31, 26	-78.8%
3Y	$735.07M	Sep 30, 24	-81.7%
5Y	$750.68M	N/A	-82.1%
All	$1.34B	Dec 31, 19	-90.0%

Quarterly EBITDA Lows

RPRX Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$134.41M	Jun 30, 26	at low
3Y	-$73.77M	Mar 31, 24	+282.2%
5Y	-$73.77M	Mar 31, 24	+282.2%
All	-$73.77M	Mar 31, 24	+282.2%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$134.41M	-78.8%
Mar 2026	$633.65M	+62.8%
Dec 2025	$389.20M	-9.2%
Sep 2025	$428.43M	+104.2%
Jun 2025	$209.80M	-60.7%
Mar 2025	$534.18M	+48.0%
Dec 2024	$361.00M	-50.9%
Sep 2024	$735.07M	+172.6%
Jun 2024	$269.63M	+465.5%
Mar 2024	-$73.77M	-112.0%
Dec 2023	$613.00M	+304.8%
Sep 2023	$151.44M	-39.1%
Jun 2023	$248.84M	-48.0%
Mar 2023	$478.97M	+260.1%
Dec 2022	$133.00M	-30.8%

Month	Value	Change
Sep 2022	$192.21M	-49.1%
Jun 2022	$377.79M	+67.6%
Mar 2022	$225.39M	+41.8%
Dec 2021	$159.00M	-48.5%
Sep 2021	$308.85M	-58.9%
Jun 2021	$750.68M	+219.5%
Mar 2021	$234.97M	-26.6%
Dec 2020	$320.00M	-38.0%
Sep 2020	$516.36M	+24.4%
Jun 2020	$415.08M	+13.1%
Mar 2020	$367.16M	-72.6%
Dec 2019	$1.34B	+148.5%
Sep 2019	$538.29M	+61.4%
Jun 2019	$333.59M	-23.8%
Mar 2019	$437.50M	-

FAQ

What is the current quarterly EBITDA of RPRX?: As of today, RPRX quarterly EBITDA is $134.41M
What is RPRX quarterly EBITDA most recent change?: RPRX quarterly EBITDA was down -78.79% on June 30, 2026
What is 1-year change in RPRX quarterly EBITDA?: RPRX quarterly EBITDA is down -35.93% year-over-year
How far is RPRX quarterly EBITDA from its all-time high?: RPRX quarterly EBITDA is currently -89.95% below its historical high of $1.34B set on December 31, 2019
How does RPRX quarterly EBITDA rank versus sector peers?: RPRX quarterly EBITDA is higher than 89.25% of companies in Healthcare sector
When is RPRX next earnings release?: The next earnings release for RPRX is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.59B$75.39M-4.54%

June 30, 2026

Summary

Current Value: As of today, RPRX TTM EBITDA is $1.59B, down -4.54% on June 30, 2026
Historical Performance: RPRX TTM EBITDA is down -13.82% year-over-year, up +50.59% over the past 3 years
All-Time High Comparison: RPRX TTM EBITDA is currently -40.35% below its historical high of $2.66B set on June 30, 2020
3-Year Low Comparison: RPRX TTM EBITDA is +68.78% above its 3-year low of $939.51M reached on March 31, 2024
Sector Comparison: RPRX TTM EBITDA is higher than 94.29% of companies in Healthcare sector

Performance

RPRX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	$1.59B	-4.5%	-13.8%	+50.6%	-13.0%
Annual EBITDA	Dec 31, 25	$1.56B	–	+21.0%	+68.4%	-3.4%
Quarterly EBITDA	Jun 30, 26	$134.41M	-78.8%	-35.9%	-46.0%	-82.1%
Price	Aug 14, 26	$58.60	+9.7%	+60.5%	+94.6%	+51.3%
PE Ratio	Aug 14, 26	31.20	+11.8%	+85.5%	-41.5%	+99.7%
TTM Revenue	Jun 30, 26	$2.54B	+3.9%	+10.0%	+7.4%	+13.3%
TTM EPS	Jun 30, 26	$1.88	-1.8%	-13.4%	+232.5%	-24.3%
	Jun 30, 26	$1.58B	-4.6%	-14.1%	+50.1%	-12.1%
TTM Net Income	Jun 30, 26	$1.35B	-0.8%	-19.0%	+186.7%	-31.0%

TTM EBITDA Highs

RPRX TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.84B	N/A	-13.8%
3Y	$1.90B	Mar 31, 25	-16.5%
5Y	$1.90B	Mar 31, 25	-16.5%
All	$2.66B	Jun 30, 20	-40.4%

TTM EBITDA Lows

RPRX TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.53B	Sep 30, 25	+3.4%
3Y	$939.51M	Mar 31, 24	+68.8%
5Y	$928.39M	Dec 31, 22	+70.8%
All	$437.50M	Mar 31, 19	+262.4%

TTM EBITDA History

Month	Value	Change
Jun 2026	$1.59B	-4.5%
Mar 2026	$1.66B	+6.4%
Dec 2025	$1.56B	+1.8%
Sep 2025	$1.53B	-16.7%
Jun 2025	$1.84B	-3.1%
Mar 2025	$1.90B	+47.1%
Dec 2024	$1.29B	-16.3%
Sep 2024	$1.54B	+60.8%
Jun 2024	$960.30M	+2.2%
Mar 2024	$939.51M	-37.0%
Dec 2023	$1.49B	+47.4%
Sep 2023	$1.01B	-3.9%
Jun 2023	$1.05B	-10.9%
Mar 2023	$1.18B	+27.3%
Dec 2022	$928.39M	-2.7%

Month	Value	Change
Sep 2022	$954.39M	-10.9%
Jun 2022	$1.07B	-25.8%
Mar 2022	$1.44B	-0.7%
Dec 2021	$1.45B	-10.0%
Sep 2021	$1.61B	-11.4%
Jun 2021	$1.82B	+22.6%
Mar 2021	$1.49B	-8.2%
Dec 2020	$1.62B	-38.6%
Sep 2020	$2.64B	-0.8%
Jun 2020	$2.66B	+3.2%
Mar 2020	$2.58B	-2.7%
Dec 2019	$2.65B	+102.2%
Sep 2019	$1.31B	+69.8%
Jun 2019	$771.09M	+76.2%
Mar 2019	$437.50M	-

FAQ

What is the current TTM EBITDA of RPRX?: As of today, RPRX TTM EBITDA is $1.59B
What is RPRX TTM EBITDA most recent change?: RPRX TTM EBITDA was down -4.54% on June 30, 2026
What is 1-year change in RPRX TTM EBITDA?: RPRX TTM EBITDA is down -13.82% year-over-year
How far is RPRX TTM EBITDA from its all-time high?: RPRX TTM EBITDA is currently -40.35% below its historical high of $2.66B set on June 30, 2020
How does RPRX TTM EBITDA rank versus sector peers?: RPRX TTM EBITDA is higher than 94.29% of companies in Healthcare sector
When is RPRX next earnings release?: The next earnings release for RPRX is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

RPRX Official Website www.royaltypharma.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx